ロード中...
KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4
Kinesin family member 23 (KIF23), a nuclear protein and a key regulator of cellular cytokinesis, has been found to be overexpressed as an oncogene in glioma. However, the prognostic and clinicopathological features of glioma with KIF23 expression was not clear yet. Here, we analyzed KIF23 expression...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029730/ https://ncbi.nlm.nih.gov/pubmed/27013586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8261 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|